Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of the American Academy of Dermatology
|
December 28, 2025
Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
Dermatology and Therapy
|
May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Lawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.
Dermatology and Therapy
|
October 21, 2022
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
Amy S Paller, Gil Yosipovitch, Stephan Weidinger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 4, 2025
Dupilumab improves quality of life assessed by the Quality of Life in Hand Eczema Questionnaire
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
Dermatology and Therapy
|
October 29, 2021
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
Gil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong, et al.
Dermatology and Therapy
|
August 8, 2023
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
Alexa B Kimball, Dimittri Delevry, Min Yang, et al.
American Journal of Clinical Dermatology
|
May 14, 2022
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Andrew Blauvelt, Emma Guttman-Yassky, Amy S Paller, et al.
The Journal of Pediatrics
|
May 1, 2022
The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study
Sebastien Barbarot, Jonathan I Silverberg, Abhijit Gadkari, et al.
The British Journal of Dermatology
|
December 4, 2023
Burden of atopic dermatitis in paediatric patients: an international cross-sectional study
Stephan Weidinger, Eric L Simpson, Jonathan I Silverberg, et al.
Journal of the American Academy of Dermatology
|
January 31, 2024
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Eric L Simpson, Jonathan I Silverberg, Margitta Worm, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of the American Academy of Dermatology
|
December 28, 2025
Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
Dermatology and Therapy
|
May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Lawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.
Dermatology and Therapy
|
October 21, 2022
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
Amy S Paller, Gil Yosipovitch, Stephan Weidinger, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 4, 2025
Dupilumab improves quality of life assessed by the Quality of Life in Hand Eczema Questionnaire
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
Dermatology and Therapy
|
October 29, 2021
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis
Gil Yosipovitch, Marjolein de Bruin-Weller, April Armstrong, et al.
Dermatology and Therapy
|
August 8, 2023
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
Alexa B Kimball, Dimittri Delevry, Min Yang, et al.
American Journal of Clinical Dermatology
|
May 14, 2022
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Andrew Blauvelt, Emma Guttman-Yassky, Amy S Paller, et al.
The Journal of Pediatrics
|
May 1, 2022
The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study
Sebastien Barbarot, Jonathan I Silverberg, Abhijit Gadkari, et al.
The British Journal of Dermatology
|
December 4, 2023
Burden of atopic dermatitis in paediatric patients: an international cross-sectional study
Stephan Weidinger, Eric L Simpson, Jonathan I Silverberg, et al.
Journal of the American Academy of Dermatology
|
January 31, 2024
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Eric L Simpson, Jonathan I Silverberg, Margitta Worm, et al.
Page
of 2